News & Updates

Lupus nephritis carries higher adverse outcomes in kids on dialysis

28 Apr 2022

Among children and adolescents undergoing maintenance dialysis, those with lupus nephritis are at higher risk of adverse outcomes, including hospitalization, and are less likely to receive kidney transplantation compared with those who have non-lupus glomerular disease, a study has found.

Lupus nephritis carries higher adverse outcomes in kids on dialysis

28 Apr 2022

Adjunctive mavacamten averts need for invasive therapy in OHCM

28 Apr 2022 by

Adding mavacamten – an allosteric modulator of cardiac myosin – to maximal medical therapy slashes the need for septal reduction therapy (SRT) in patients with obstructive hypertrophic cardiomyopathy (OHCM) who are candidates for such intervention, the VALOR-HCM trial has shown.

Adjunctive mavacamten averts need for invasive therapy in OHCM

28 Apr 2022

Annual flu jab in HF patients may lower hospitalization, pneumonia risk

27 Apr 2022 by

An annual influenza vaccination does not lower the risk of cardiovascular (CV) outcomes in patients with heart failure (HF), though it may reduce the risk of pneumonia and hospitalization, according to results of the IVVE study presented at ACC.22.

Annual flu jab in HF patients may lower hospitalization, pneumonia risk

27 Apr 2022

Hypertriglyceridemia tied with severe acute pancreatitis

27 Apr 2022

The risk of severe acute pancreatitis appears to be significantly and independently associated with hypertriglyceridemia, reports a recent study.

Hypertriglyceridemia tied with severe acute pancreatitis

27 Apr 2022

Stem cells may hold the answer to our problems associated with ageing and frailty.

27 Apr 2022 by

Frailty is an age-related disability characterized by generalized weakness, impaired mobility and balance, poor endurance, and decline in organ physiologic reserve and loss of homeostasis. It is a syndrome of multisystem reduction in physical capacity (caused by muscle loss) that leads to loss of independence.

Stem cells may hold the answer to our problems associated with ageing and frailty.

27 Apr 2022

Rhythm control should be started earlier in women vs men

27 Apr 2022 by

Early initiation of rhythm control for atrial fibrillation (AF) appears to be favourable, but women should start rhythm control treatment earlier than men to get the best possible outcomes, according to a study presented at the annual meeting of the European Heart Rhythm Association (EHRA).

Rhythm control should be started earlier in women vs men

27 Apr 2022

Urinary angiotensinogen linked to renal arteriolar remodeling in CKD

27 Apr 2022

Renal renin‒angiotensin system (RAS) appears to contribute to renal arteriolar remodeling and future decline in estimated glomerular filtration rate (eGFR), irrespective of potential risk factors, in patients with chronic kidney disease (CKD), a study has found.

Urinary angiotensinogen linked to renal arteriolar remodeling in CKD

27 Apr 2022

Cochlear implant corrects hearing but does not translate to actual perceived benefits

27 Apr 2022 by

Cochlear implantation (CI) improves both audiologic and tinnitus outcome measures in patients with single-sided deafness (SSD), but the speech discrimination score (SDS) remains in nonserviceable range, while only a modest improvement is seen in quality-of-life (QoL) measures, reports a Singapore study.

Cochlear implant corrects hearing but does not translate to actual perceived benefits

27 Apr 2022

Long-term antihypertensive therapy beneficial for myocardial strain

27 Apr 2022

Antihypertensive treatment provides benefits on left ventricular (LV) mechanisms, suggest the results of a meta-analysis, noting that improvement in global longitudinal strain (GLS) is associated with the reduction in LV mass index (LVMI) instead of systolic blood pressure (SBP).

Long-term antihypertensive therapy beneficial for myocardial strain

27 Apr 2022

Novel drug helps optimize HFrEF therapy

27 Apr 2022 by

In individuals receiving renin-angiotensin-aldosterone system inhibitor (RAASi) therapy for heart failure with reduced ejection fraction (HFrEF), the novel potassium binder patiromer effectively reduced serum potassium levels, the DIAMOND trial suggests, thus optimizing a guideline-directed RAASi therapy for these patients.

Novel drug helps optimize HFrEF therapy

27 Apr 2022

News & Updates

Filter by Specialty:

Specialty:

Lupus nephritis carries higher adverse outcomes in kids on dialysis

Lupus nephritis carries higher adverse outcomes in kids on dialysis

Adjunctive mavacamten averts need for invasive therapy in OHCM

Adjunctive mavacamten averts need for invasive therapy in OHCM

Annual flu jab in HF patients may lower hospitalization, pneumonia risk

Annual flu jab in HF patients may lower hospitalization, pneumonia risk

Hypertriglyceridemia tied with severe acute pancreatitis

Hypertriglyceridemia tied with severe acute pancreatitis

Stem cells may hold the answer to our problems associated with ageing and frailty.

Stem cells may hold the answer to our problems associated with ageing and frailty.

Rhythm control should be started earlier in women vs men

Rhythm control should be started earlier in women vs men

Urinary angiotensinogen linked to renal arteriolar remodeling in CKD

Urinary angiotensinogen linked to renal arteriolar remodeling in CKD

Cochlear implant corrects hearing but does not translate to actual perceived benefits

Cochlear implant corrects hearing but does not translate to actual perceived benefits

Long-term antihypertensive therapy beneficial for myocardial strain

Long-term antihypertensive therapy beneficial for myocardial strain

Novel drug helps optimize HFrEF therapy

Novel drug helps optimize HFrEF therapy